Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
No drug on the market, as a single entity, participates in different pathways involved in the pathology of Alzheimer’s disease. The current study is aimed at the exploration of multifunctional chalcone derivatives which can act on multiple targets involved in Alzheimer’s disease. A series of novel a...
Main Authors: | Pratibha Sharma, Manjinder Singh, Varinder Singh, Thakur Gurjeet Singh, Tanveer Singh, Sheikh F. Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/18/6579 |
Similar Items
-
Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
by: Shiveena Bhatia, et al.
Published: (2023-08-01) -
Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer’s Disease
by: Angela Rampa, et al.
Published: (2018-07-01) -
Naturally Occurring Chalcones with Aggregation-Induced Emission Enhancement Characteristics
by: Iwona Budziak-Wieczorek, et al.
Published: (2023-04-01) -
Inhibitory Evaluation of Sulfonamide Chalcones on β-Secretase and Acylcholinesterase
by: Dae Wook Kim, et al.
Published: (2012-12-01) -
Synthesis of prenylated chalcone /
by: Beh, Gein Khai, 1986-, et al.
Published: (2010)